Research & Development

Sysmex RDCE is endeavoring to create new clinical value for personalized medicine through open innovation – generating synergy by combining the technology and knowledge possessed by universities and research institutes with our own.

Our R&D activities through open innovation include:

  • R&D of applications in a variety of disease fields on our technology platforms such as for genes, cells and proteins, and
  • R&D of elemental technologies in areas such as biology, chemistry, information science, electronic engineering etc.

Our R&D activities thorough open innovation are;

  • R&D of applications on our variety of technology platforms, such as for genes, cells and proteins, and
  • R&D of elemental technologies in the area such as biology, chemistry, information science, electronic engineering etc.
Copyright © Sysmex Europe GmbH. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.